FDA Inspection
Biogen U.S. CorporationFDA Inspection 1220500 - Biogen U.S. Corporation - October 17, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Biogen U.S. Corporation, with an inspection on October 17, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
Open in Dashboard
ID · 900286c7-188d-48a4-afa8-5f32b90599d4
Violation Codes5
21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.160(b)21 CFR 211.19221 CFR 211.198(a)
Full citation text and observation details available on the Dashboard.